Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A18900 | 26880573 | J Hepatobiliary Pancreat Sci | Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease. | 2016 | Details |
A18923 | 26869052 | BMC Cardiovasc Disord | Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka. | 2016 | Details |
A18946 | 26856683 | Clin Obes | Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. | 2016 | Details |
A18982 | 26834493 | Clin Exp Gastroenterol | Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. | 2016 | Details |
A19002 | 26825357 | Curr Opin Organ Transplant | Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. | 2016 | Details |
A19028 | 26812459 | J Adolesc Young Adult Oncol | Metabolic Health in Childhood Cancer Survivors: A Longitudinal Study in a Long-Term Follow-Up Clinic. | 2015 | Details |
A19059 | 26792853 | QJM | Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test. | 2016 | Details |
A19061 | 26791191 | Am J Clin Nutr | Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. | 2016 | Details |
A19096 | 26770322 | Int J Clin Exp Med | Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway. | 2015 | Details |
A19186 | 28670148 | Clin Med Insights Ther | Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. | 2016 | Details |
A19189 | 28525217 | Rev Med Brux | [Psoriasis in 2016 : Co-morbidities and therapeutic update]. | 2019 | Details |
A19200 | 26707365 | Hepatology | Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | 2016 | Details |
A19205 | 26703429 | Eur J Intern Med | Uric acid in metabolic syndrome: From an innocent bystander to a central player. | 2015 | Details |
A19244 | 26675585 | BBA Clin | Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. | 2014 | Details |
A19262 | 26667615 | Vnitr Lek | [Approach to patients with liver diseases]. | 2015 | Details |
A19308 | 26636408 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. | 2016 | Details |
A19338 | 26621325 | J Diabetes | Soluble epoxide hydrolase: A potential target for metabolic diseases. | 2016 | Details |
A19345 | 26618774 | PLoS One | A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. | 2015 | Details |
A19354 | 26610680 | Radiologe | [Functional MR imaging of the liver]. | 2015 | Details |
A19357 | 26609343 | World J Hepatol | Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. | 2015 | Details |
A19378 | 26599575 | PLoS One | Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features. | 2015 | Details |
A19381 | 26599080 | PLoS One | The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. | 2015 | Details |
A19382 | 26598837 | J Nutr Sci Vitaminol (Tokyo) | Lipid Nutrition and Healthy Aging. | 2015 | Details |
A19385 | 26597602 | J Diabetes Complications | Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertension. | 2015 | Details |
A19403 | 26589761 | J Gastroenterol Hepatol | The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
A19415 | 26581602 | Exp Clin Transplant | Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis. | 2015 | Details |
A19435 | 26571018 | PLoS One | High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis. | 2015 | Details |
A19470 | 26545658 | Nutr Hosp | NUTRITIONAL STATUS, DIET AND NON-ALCOHOLIC FATTY LIVER DISEASE IN ELDERS. | 2015 | Details |
A19478 | 26537011 | J Eur Acad Dermatol Venereol | Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis. | 2015 | Details |
A19521 | 26512643 | Int J Mol Sci | Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
A19536 | 26503843 | Liver Int | The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. | 2015 | Details |
A19558 | 26486292 | Arq Gastroenterol | INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. | 2016 | Details |
A19568 | 26477387 | Pharmacol Res | Cyanidin 3-glucoside improves diet-induced metabolic syndrome in rats. | 2015 | Details |
A19575 | 26475841 | Perit Dial Int | Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients. | 2015 | Details |
A19618 | 26454786 | Dig Liver Dis | Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. | 2015 | Details |
A19629 | 26447961 | J Clin Gastroenterol | Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. | 2016 | Details |
A19633 | 26447006 | JBI Database System Rev Implement Rep | Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol. | 2015 | Details |
A19637 | 26444605 | Clin Hemorheol Microcirc | Association of whole blood viscosity with non-alcoholic fatty liver disease. | 2015 | Details |
A19642 | 26441288 | Aten Primaria | [Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care]. | 2015 | Details |
A19643 | 26441244 | PLoS One | Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients. | 2015 | Details |
A19654 | 26435078 | Metabolism | The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. | 2015 | Details |
A19672 | 26423094 | J Endocrinol | Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. | 2015 | Details |
A19678 | 28294798 | Kardiologiia | [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. | 2015 | Details |
A19684 | 26412465 | Curr Pharm Des | Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome. | 2015 | Details |
A19685 | 26411937 | Nihon Eiseigaku Zasshi | [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. | 2015 | Details |
A19692 | 26407654 | Eur J Pharmacol | Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients. | 2015 | Details |
A19698 | 26405708 | J Gastrointestin Liver Dis | Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity? | 2015 | Details |
A19720 | 26395497 | BMJ Open | Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. | 2015 | Details |
A19756 | 26378573 | Nutrients | Green and Black Cardamom in a Diet-Induced Rat Model of Metabolic Syndrome. | 2015 | Details |
A19781 | 26355033 | Sci Transl Med | Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. | 2015 | Details |
A19806 | 26339423 | Int J Clin Exp Pathol | Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease. | 2015 | Details |
A19809 | 26337107 | Curr Med Chem | Emerging Vascular Risk Factors in Women: Any Differences from Men? | 2015 | Details |
A19815 | 26330344 | Am J Physiol Endocrinol Metab | Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. | 2015 | Details |
A19834 | 26316717 | Drug Des Devel Ther | Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. | 2015 | Details |
A19840 | 26315331 | Diabet Med | Diabetic hepatosclerosis: another diabetes microvascular complication? | 2016 | Details |
A19849 | 28943619 | Diseases | MOGAT2: A New Therapeutic Target for Metabolic Syndrome. | 2015 | Details |
A19901 | 26276551 | BMC Endocr Disord | Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. | 2015 | Details |
A19920 | 26265520 | Arch Iran Med | PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol. | 2015 | Details |
A19924 | 26263022 | Sci Rep | Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. | 2015 | Details |
A19931 | 26256971 | Yonsei Med J | Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis. | 2015 | Details |
A19941 | 26252899 | PLoS One | Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes. | 2015 | Details |
A19948 | 26247669 | Clinics (Sao Paulo) | Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study. | 2015 | Details |
A19958 | 26240695 | World J Diabetes | Metabolic surgery: A paradigm shift in type 2 diabetes management. | 2015 | Details |
A19973 | 26232233 | Am J Physiol Heart Circ Physiol | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. | 2015 | Details |
A19978 | 26228676 | J Clin Lipidol | Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. | 2015 | Details |
A20050 | 26190559 | Food Funct | Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. | 2015 | Details |
A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
A20074 | 26174761 | Arab J Gastroenterol | Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit? | 2015 | Details |
A20082 | 26169265 | Cardiovasc Diabetol | Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. | 2015 | Details |
A20089 | 26167086 | World J Gastroenterol | Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. | 2015 | Details |
A20094 | 26159280 | Dig Dis | Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. | 2015 | Details |
A20095 | 26157039 | Ultrason Imaging | Doppler Tissue Evaluation of Atrial Conduction Properties in Patients With Non-alcoholic Fatty-liver Disease. | 2015 | Details |
A20096 | 26156527 | Diabetes Care | Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes. | 2015 | Details |
A20117 | 26144271 | Metabolism | Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study. | 2015 | Details |
A20133 | 26134926 | Expert Opin Drug Saf | Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | 2015 | Details |
A20135 | 26133980 | Liver Int | Probe-based confocal laser endomicroscopy quantitative morphometric markers associated with portal hypertension in duodenal mucosa. | 2015 | Details |
A20169 | 26113985 | Open Heart | Capsaicin may have important potential for promoting vascular and metabolic health. | 2015 | Details |
A20197 | 26090093 | J Nutr Sci | Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies. | 2015 | Details |
A20206 | 26085300 | Sleep | Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. | 2015 | Details |
A20212 | 26080905 | Minerva Gastroenterol Dietol | The diagnosis and treatment of non-alcoholic fatty liver disease. | 2015 | Details |
A20234 | 26072069 | J Huazhong Univ Sci Technolog Med Sci | Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease. | 2015 | Details |
A20269 | 26052389 | World J Hepatol | Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal. | 2015 | Details |
A20270 | 26052382 | World J Hepatol | Non-alcoholic fatty liver disease - the heart of the matter. | 2015 | Details |
A20271 | 26052378 | World J Hepatol | Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
A20312 | 26034364 | World J Gastroenterol | Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. | 2015 | Details |
A20330 | 26026390 | Gastroenterology | High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. | 2015 | Details |
A20337 | 26024397 | Rocz Panstw Zakl Hig | Health effects of changes in the structure of dietary macronutrients intake in western societies. | 2015 | Details |
A20343 | 26020401 | Medicine (Baltimore) | Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study. | 2015 | Details |
A20413 | 25984671 | Medicine (Baltimore) | Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease. | 2015 | Details |
A20445 | 25958919 | Clin Exp Dermatol | Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. | 2015 | Details |
A20468 | 25941433 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. | 2015 | Details |
A20477 | 25937862 | World J Hepatol | Non-alcoholic fatty liver disease: The diagnosis and management. | 2015 | Details |
A20525 | 25910371 | Turk J Gastroenterol | The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. | 2014 | Details |
A20559 | 25887357 | Diabetes Care | Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. | 2015 | Details |
A20579 | 25875119 | Nutrients | A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats. | 2015 | Details |
A20585 | 25871295 | Mar Drugs | Anti-obesity activity of the marine carotenoid fucoxanthin. | 2015 | Details |
A20622 | 25848465 | World J Hepatol | Angiogenesis and liver fibrosis. | 2015 | Details |
A20634 | 25844093 | Diabetol Metab Syndr | Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c. | 2015 | Details |
A20645 | 25835982 | Obes Surg | Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. | 2015 | Details |
A20653 | 25830307 | Ann Gastroenterol | Metabolic and cardiovascular complications in the liver transplant recipient. | 2020 | Details |